A hard-fought campaign to reduce the exorbitant price of insulin seems to finally be yielding some results.
On Wednesday, drugmaker Eli Lilly announced it would slash the price of the lifesaving drug by over 70 percent and cap out-of-pocket costs at $35 a month for most patients. Non-branded insulin will fall to just $25 a bottle from its current price of $82.41—a major win for the 7.5 million Americans who rely on insulin but still orders of magnitude above the drug’s single-digit price tag in many high-income countries.
The cuts expand on a clause of the Inflation Reduction Act passed by Democrats in August, which capped the price of insulin at $35 for Medicare recipients since Jan. 1. Though insulin is cheap to manufacture, its retail price has skyrocketed in the U.S. in recent years, climbing over 54 percent between 2014 and 2019.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Drugs giant Eli Lilly caps monthly insulin costs in US at $35The cap on the diabetes medication by the drugs giant could bring cost relief to million of Americans.
Read more »
Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketThe moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
Read more »
Eli Lilly caps the cost of insulin at $35 a monthThe move puts the drugmaker in line with a popular provision in the Inflation Reduction Act that capped the medication’s cost for seniors on Medicare.
Read more »
Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millionsEli Lilly will cap the out-of-pocket cost of its insulin at $35 a month, the drugmaker said Wednesday. The move, experts say, could prompt other insulin makers in the U.S. to follow suit.
Read more »
Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millionsThe move puts the drugmaker in line with a popular provision in the Inflation Reduction Act that capped the medication’s cost for seniors on Medicare.
Read more »
Eli Lilly to cut insulin prices by 70%, cap monthly costs at $35The price reductions for the life-saving medication come amid criticism that unaffordable insulin may constitute a human rights abuse.
Read more »